In this paper we discuss the results of the coupled in silico/experimental approach to the resistance phenomena in cancer targeted therapy of tyrosin kinase mutations.
Sensitivity To Novel Tyrosine Kinase Inhibitors of Highly Resistant Single and Polymutant Bcr-abl1: A Combined Approach
PRICL, SABRINA;LAURINI, ERIK;POSOCCO, PAOLA;FERMEGLIA, MAURIZIO;
2012-01-01
Abstract
In this paper we discuss the results of the coupled in silico/experimental approach to the resistance phenomena in cancer targeted therapy of tyrosin kinase mutations.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
